Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

AGIO holding history

Agios Pharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AGIO overviewAll 13F holders of AGIOFull Q2 2026 holdings

Shares (Q2 2026)
3,107,005
Value
$115.3M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of AGIO by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,107,005$115.3M0.1%+425,836+15.9%AddedHolders
Q1 20262,681,169$90.7M0.1%+843,983+45.9%AddedHolders
Q4 20251,837,186$50.0M<0.1%+1,469,437+399.6%AddedHolders
Q3 2025367,749$14.8M<0.1%−228,453−38.3%ReducedHolders
Q2 2025596,202$19.8M<0.1%+41,382+7.5%AddedHolders
Q1 2025554,820$16.3M<0.1%+38,345+7.4%AddedHolders
Q4 2024516,475$17.0M<0.1%−15,929−3.0%ReducedHolders
Q3 2024532,404$23.7M<0.1%−145,830−21.5%ReducedHolders
Q2 2024678,234$29.2M<0.1%+316,100+87.3%AddedHolders
Q1 2024362,134$10.6M<0.1%+145,650+67.3%AddedHolders
Q4 2023216,484$4.82M<0.1%+58,204+36.8%AddedHolders
Q3 2023158,280$3.92M<0.1%+62,420+65.1%AddedHolders
Q2 202395,860$2.71M<0.1%−6,286−6.2%ReducedHolders
Q1 2023102,146$2.35M<0.1%−63,652−38.4%ReducedHolders
Q4 2022165,798$4.66M<0.1%−125,493−43.1%ReducedHolders
Q3 2022291,291$8.24M<0.1%+14,872+5.4%AddedHolders
Q2 2022276,419$6.13M<0.1%+225,876+446.9%AddedHolders
Q1 202250,543$1.47M<0.1%−63,323−55.6%ReducedHolders
Q4 2021113,866$3.74M<0.1%−26,888−19.1%ReducedHolders
Q3 2021140,754$6.50M<0.1%+119,366+558.1%AddedHolders
Q2 202121,388$1.18M<0.1%−64,970−75.2%ReducedHolders
Q1 202186,358$4.46M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.